![Bronson Crouch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 975 807 $ al 30/06/2026
Bronson Crouch is Chairman & Chief Executive Officer at Instil Bio, Inc. since 2018.
Mr. Crouch is Managing Partner at Peloton Therapeutics, Inc. and TCR² Therapeutics, Inc. Mr. Crouch is Founding Partner at Curative Ventures Management LLC since 2014.
Former roles include Managing Partner at CoStim Pharmaceuticals, Inc. and Managing Partner at iTeos Therapeutics, Inc.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
INSTIL BIO, INC. 1,87 % | 13/04/2026 | 126.893 ( 1,87 % ) | 975 807 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| INSTIL BIO, INC. | Director Ejecutivo | 01/11/2018 |
| TCR2 THERAPEUTICS INC. | Corporate Officer/Principal | - |
| PELOTON THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Curative Ventures Management LLC
 Curative Ventures Management LLC Investment ManagersFinance Curative Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare technologies sector. It provides financing for early stage capital requirements | Inversor de Capital Privado | 01/01/2014 |
| Empresas | Cargo | Fin |
|---|---|---|
| ITEOS THERAPEUTICS, INC. | Corporate Officer/Principal | - |
CoStim Pharmaceuticals, Inc.
 CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
Peloton Therapeutics, Inc.
 Peloton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which engages in developing and researching drugs for cancer patients | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotech company which develops biologics for oncology indications | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Curative Ventures Management LLC
Curative Ventures Management LLC Investment ManagersFinance Curative Ventures invests in companies located in the United States. The firm targets companies operating in the fields of healthcare technologies sector. It provides financing for early stage capital requirements | Finance |
Instil Bio, Inc.
 Instil Bio, Inc. BiotechnologyHealth Technology Develops tumour infiltrating lymphocytes for the treatment of cancer | Health Technology |
iTeos Therapeutics, Inc.
 iTeos Therapeutics, Inc. BiotechnologyHealth Technology Develops immunomodulators for cancer treatments | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
